Response to Commentary on '"Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".
作者信息
Bolm Louisa, Nebbia Martina, Wei Alice C, Zureikat Amer H, Fernández-Del Castillo Carlos, Zheng Jian, Pulvirenti Alessandra, Javed Ammar A, Sekigami Yurie, Petruch Natalie, Qadan Motaz, Lillemoe Keith D, He Jin, Ferrone Cristina R
机构信息
From the Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
出版信息
Ann Surg Open. 2023 Apr 17;4(2):e277. doi: 10.1097/AS9.0000000000000277. eCollection 2023 Jun.
Abstract
摘要
相似文献
1
Response to Commentary on '"Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".对《“大型多中心队列中直径<3 cm的无功能性胰腺神经内分泌肿瘤患者的实质保留与肿瘤切除的长期结局”》评论的回应
Ann Surg Open. 2023 Apr 17;4(2):e277. doi: 10.1097/AS9.0000000000000277. eCollection 2023 Jun.
2
Comment on "Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".关于“大型多中心队列中直径<3 cm的无功能性胰腺神经内分泌肿瘤患者的保留实质和肿瘤切除的长期结局”的评论
Ann Surg Open. 2023 Mar 14;4(1):e266. doi: 10.1097/AS9.0000000000000266. eCollection 2023 Mar.
3
Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.散发性切除的小（≤2厘米）无功能胰腺神经内分泌肿瘤的恶性风险及预后
Gland Surg. 2021 Jan;10(1):219-232. doi: 10.21037/gs-20-582.
4
Comment on: Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Nonfunctional Pancreatic Neuroendocrine Tumors?关于《保留实质的切除术真的适用于小（<3 cm）无功能胰腺神经内分泌肿瘤吗？》的评论
Ann Surg Open. 2023 Jan 30;4(1):e249. doi: 10.1097/AS9.0000000000000249. eCollection 2023 Mar.
5
[Long-term results after parenchyma-sparing vs. oncologic resection of nonfunctional pancreatic neuroendocrine neoplasms < 3 cm].[小于3厘米的无功能性胰腺神经内分泌肿瘤保留实质与肿瘤切除术后的长期结果]
Chirurgie (Heidelb). 2023 Apr;94(4):365-366. doi: 10.1007/s00104-023-01843-8. Epub 2023 Feb 27.
6
Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study Protocol.小胰腺神经内分泌肿瘤（<2 cm）的标准胰腺切除术与保留实质切除术的肿瘤学和手术结果比较：Pancreas2000研究与教育项目（课程9）研究方案。
Front Med (Lausanne). 2020 Sep 10;7:559. doi: 10.3389/fmed.2020.00559. eCollection 2020.
7
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.胰腺神经内分泌肿瘤的保守治疗和保留实质的切除术：文献回顾。
Int J Surg. 2015 Sep;21 Suppl 1:S10-4. doi: 10.1016/j.ijsu.2015.04.089. Epub 2015 Jun 26.
8
Response to Commentary "Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Non-Functional Pancreatic Neuroendocrine Tumors?".对评论文章《保留实质的切除术真的适用于小（<3厘米）无功能胰腺神经内分泌肿瘤吗？》的回应
Ann Surg Open. 2023 Feb 20;4(1):e245. doi: 10.1097/AS9.0000000000000245. eCollection 2023 Mar.
9
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study.散发性无功能性胰腺神经内分泌肿瘤：根据肿瘤大小判断淋巴结转移风险和侵袭性：一项多中心国际研究。
Surgery. 2022 Sep;172(3):975-981. doi: 10.1016/j.surg.2022.04.013. Epub 2022 May 24.
10
Parenchyma-sparing resections for pancreatic neoplasms.胰腺肿瘤的保留胰腺实质切除术。
J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):782-7. doi: 10.1007/s00534-009-0224-1. Epub 2009 Oct 29.
本文引用的文献
1
Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.在大型多中心队列中，对于<3cm 的无功能性胰腺神经内分泌肿瘤患者，行保留实质和肿瘤切除的长期结果。
Ann Surg. 2022 Sep 1;276(3):522-531. doi: 10.1097/SLA.0000000000005559. Epub 2022 Jun 27.
2
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study.无症状散发性无功能胰腺神经内分泌肿瘤（ASPEN）≤2 cm的管理：一项前瞻性观察性研究的研究方案
Front Med (Lausanne). 2020 Dec 23;7:598438. doi: 10.3389/fmed.2020.598438. eCollection 2020.
3
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.北美神经内分泌肿瘤学会关于胰腺神经内分泌肿瘤手术治疗的共识文件。
Pancreas. 2020 Jan;49(1):1-33. doi: 10.1097/MPA.0000000000001454.
4
Endoscopic ultrasound-guided fine-needle aspiration vs fine-needle biopsy for the diagnosis of pancreatic neuroendocrine tumors.内镜超声引导下细针穿刺抽吸术与细针活检术在胰腺神经内分泌肿瘤诊断中的应用比较
Endosc Int Open. 2019 Nov;7(11):E1393-E1399. doi: 10.1055/a-0967-4684. Epub 2019 Oct 22.
5
Prognostic Utility of Total Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors.总镓- DOTATATE摄取肿瘤体积在神经内分泌肿瘤患者中的预后价值
Gastroenterology. 2018 Mar;154(4):998-1008.e1. doi: 10.1053/j.gastro.2017.11.008. Epub 2017 Nov 16.
Zotero 插件